Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation

Tyrosine Kinase Inhibitors Improved Survival of Critically Ill EGFR-Mutant Lung Cancer Patients Undergoing Mechanical Ventilation

Background: Respiratory failure requiring mechanical ventilation is the major reason for lung cancer patients being admitted to the intensive care unit (ICU). Though molecular targeted therapies, especially epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), have largely impro...

Full description

Bibliographic Details
Main Authors: I-Hsien Lee, Ching-Yao Yang, Jin-Yuan Shih, Chong-Jen Yu
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Biomedicines
Subjects:
EGFR
lung cancer
critical care
mechanical ventilation
tyrosine kinase inhibitor
Online Access:https://www.mdpi.com/2227-9059/9/10/1416

Internet

https://www.mdpi.com/2227-9059/9/10/1416

Similar Items